Evidation
PrivateLast Round
Series E
Mar 22, 2021
Est. Valuation
$1B
Total Funding Raised
$259.2M
Company Overview
Evidation is a health technology company that provides a data analytics platform to collect and analyze continuous behavior data and healthcare information for improved health insights and outcomes.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Healthcare Analytics, Patient Engagement, Data Integration
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evidation Comparables
Compare Evidation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Koneksa Health | 77% | |
| eMed | 76% | |
| TriNetX | 76% | |
Evidation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Mar 22, 2021 | ||||
| Series D | Jul 1, 2020 | ||||
| Series C | Aug 1, 2018 | ||||
| Series B Extension | Apr 27, 2017 | ||||
| Series B | Oct 11, 2016 | ||||
Series A | Jan 1, 2015 |
Key People
Founding team and executive leadership
Evidation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series D |
| Rock Health | Series A |
| Fresco Capital | Series B |
| OMERS | Series E |
| SV Health Investors | Series D, Series C |
| A. M. Pappas & Associates | Series B |
| Kaiser Permanente Ventures | Series E |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 2, 2025
Dr. Khan joins as Executive Director of Digital Health.
- Mar 6, 2025
Collaborating to increase women's participation in cardiovascular studies.
Evidation Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Evidation's valuation, stock price, and market status.